A group of pharmacists from the company Selecta Biosciences Inc. has developed a unique tool, the vast majority of unwanted reactions from the immune system during drug therapy. The main feature of the created drug is to increase the efficiency of a number of other drugs. Many of them are vital for patients with complex and serious diseases.
For patients with rheumatoid arthritis there are not many effective drugs. One of them is adalimumab. Combined with the new means of action of adalimumab is amplified several times.
The new drugs lies with rapamycin. This coupling creates stability of the basic drug to the cells of the immune system. The result is a greater number of substances reaches its goal.